Cascade reactions of amidines with nitroallylic acetates and α-bromonitroalkenes provide potentially bioactive imidazoles in good to excellent yields in most cases. While 2,4-disubstituted imidazol-5-yl acetates are formed in the first case, 2,4-disubstituted imidazoles, bearing no substituent at position 5, are the products in the second case. These two series of imidazoles, viz. 2,4,5-trisubstituted and 2,4-disubstituted, were screened for their activity against the protozoan parasite Trypanosoma cruzi which is responsible for Chagas disease. As many as three compounds were as active as the standard benznidazole and two others were 2-3-fold more active highlighting the potential of substituted imidazoles, easily accessible from nitroalkenes, as possible anti-parasitic agents.
Introduction
Several imidazole containing compounds exhibit activity against Trypanosoma cruzi, a parasite that causes Chagas disease.
1 Synthesis and detailed evaluation of such anti-parasitic activity of imidazoles, including studies on their mechanism of action, have been reported in the recent literature.
2
Other biological properties of imidazoles and their applications for the treatment of various diseases have also been well documented (Fig. 1) . 3 The presence of imidazoles in bioactive compounds, including natural products, 4 for instance, marine alkaloids, 5 have received considerable attention. Potential applications of imidazoles in coordination chemistry 6 and as precursors to ionic liquids 7 and stable carbenes 8 are also noteworthy.
Many new multi-component 9 and metal-mediated [10] [11] [12] approaches have appeared in the literature for the synthesis of imidazoles. However, the three component reaction of 1,2-dicarbonyl compound, aldehyde and ammonia, 13 and the reaction of (α-halo)ketones or diketones with formamide/amines 14 or amidines 15 are the classical ones. Reactions of amidines with acetylenes 11 and nitroalkenes 12 also lead to substituted imidazoles. In essence, functionalized and fused imidazoles are attractive targets for synthetic chemists due to their diverse applications in chemistry and biology. 16 From another perspective, the reactivity of conjugated nitroalkenes as substrates in reactions as diverse as Michael addition, Diels-Alder reaction, 1,3-dipolar cycloaddition and Morita-Baylis-Hillman reaction has been amply demonstrated. 17 In particular, the Morita-Baylis-Hillman (MBH) 18 reaction of nitroalkenes has emerged as a convenient means of synthesizing α-functionalized nitroalkenes which could in turn serve as excellent substrates for the synthesis of complex molecules. [19] [20] [21] [22] Several carbocycles 20 and heterocycles 21, 22 have been synthesized exploiting the 1,2 or 1,3-bi-electrophilic character of the nitroallylic acetates through a cascade S N 2 or S N 2′ reaction of a binucleophile followed by an intramolecular Michael addition. Among nitroalkenes, α-bromonitroalkenes, by virtue of their 1,2-bielectrophilic character, are capable of taking part in cascade reactions with various binucleophiles. Their reaction with 1,3-dicarbonyl compounds, 23 enamines, 24 and other miscellaneous binucleophiles 25 provided various functionalized heterocycles such as furans, pyrroles, pyrazoles, and triazoles among others. However, to our knowledge, there is no report on the reaction of α-bromonitroalkenes with amidines for the synthesis of functionalized imidazoles. This work describes the full version of our studies on the synthesis of imidazoles by treating amidines with nitroallylic acetates and α-bromonitroalkenes and studies on their trypanocidal activity. 26 
Results and discussion
In our recent communication, 26 we reported the synthesis of imidazole esters 3 from nitroallylic acetates 1 and amidines 2 through a one-pot cascade intermolecular aza-S N 2′ reactionintramolecular aza-Michael addition (Table 1) . Selected imidazole esters 3 were transformed to alcohols 4, acids 5 and then to amides 6 (Scheme 1). Many of these imidazoles were screened for their activity against the protozoan parasite T. cruzi, the etiological agent of Chagas disease. In particular, the activity of imidazole esters 3a and 3b was comparable to that of the standard benznidazole. More importantly, imidazole ester 3e exhibited activity twice that of benznidazole thus prompting us to synthesize and screen more imidazoles in this series and also those with other substitution patterns. At the outset, imidazoles 3h, 3o and 3p (Table 1, entries 8,  15 and 16) and 4d, 5a, 5d, 6a and 6d (Scheme 1) which were reported in our previous communication, 26 but could not be screened earlier were later evaluated for their activity. Unfortu- In view of the above, imidazole esters 3t-v were synthesized following the general procedure reported by us earlier (Table 1, entries 20-22) . Additionally, imidazole ester 3a was transformed to alcohol 4a using LAH in 76% yield and alcohol 4a, in turn, was converted to azide 7a in 60% yield (Scheme 1). Subsequently, esters 3t-v, alcohol 4a and azide 5a were subjected to trypanocidal activity studies as reported before. However, while esters 3t-v and alcohol 4a were inactive, azide 7a showed only moderate activity (IC 50 /24 h 157.3 µM). It is worth mentioning the potential of the clickable imidazole 7a that can be considered as an important intermediate in click chemistry reactions for the synthesis of hybrid compounds.
In the above scenario, we decided to explore the possibility of synthesizing imidazoles with different substitution patterns by our own methodology and screen them for their trypanocidal activity. Interestingly, although synthesis of imidazoles of type 9 via various miscellaneous methods is known in the literature, 27-36 the reaction of amidines 2 with α-bromonitroalkenes 8 has not been employed for such purposes. At the outset, amidine 2a and α-bromonitroalkene 8a were chosen as model substrates in order to establish the optimal conditions (Table 2 ). There was no appreciable conversion when 1 equiv. of Cs 2 CO 3 was employed as a base in THF at room temperature even after 24 h (entry 1). However, upon increasing the loading of Cs 2 CO 3 to 2 and 3 equiv., there was a dramatic rise in the product yields to 55% and 85% as well as an improvement in the reaction rate to 18 h and 12 h, respectively (entries 2 and 3). While K 2 CO 3 also gave comparable yields (80%) of the product 9a (entry 4), amine bases such as DMAP, DABCO and Et 3 N were less effective (entries 5-7) under otherwise identical conditions. Finally, changing solvent to CH 3 CN enabled us to improve the yield further to 93% and considerably reduce the reaction time to 3 h (entry 8) though the yield was much lower (75%) in a hydrocarbon solvent such as toluene (entry 9).
The above optimized conditions were successfully employed for the synthesis of a variety of 2,5-disubstituted imidazoles 9 and 10 (Tables 3 and 4) . Initially, benzamidine 2a was treated with bromonitroalkenes 8 bearing various substituents at the β-position to afford imidazoles 9 (Table 3 ). In particular, bromonitroalkenes bearing electron rich aryl groups at the β-position 8a-c and 8e provided the products 9a-c and 9e, respectively, in excellent yield (>90%, entries 1-3 and 5). The only exception among nitroalkenes bearing an electron rich aryl group was 8f which afforded the product 9f in a slightly lower yield (84%) and a longer reaction time (6 h, entry 6). The yields of imidazoles derived from nitroalkenes bearing parent phenyl 8d, electron deficient aryls 8g-j and a fused aryl 8m at the β-position were in the range of 74-88% (entries 4, 7-10 and 13). Heteroaryl substituted bromonitroalkenes 8k-l also delivered the corresponding imidazoles 9k-l in good to high yield (71-85%, entries 11 and 12). While bromonitrodiene 8n afforded the product 9n in moderate yield (67%, entry 14), β-alkylated nitroalkenes 8o and p were better substrates and provided the desired imidazoles 9o-p in 75-85% yield (entries 15 and 16) .
Having demonstrated the wide scope of bromonitroalkenes 8 in the reaction with amidine 2a, the scope of amidines 2 was investigated by taking bromonitroalkene 8a as the representative substrate (Table 4 ). The reaction of 8a proceeded well with various arylamidines 2b-d to afford the products 10b-d in high yield (79-87%, entries 1-3). However, lower yield of imidazole 10e was encountered with thioamidine 2e (55%, entry 4). Guanidine 2f and formamidine 2g were not suitable substrates for the synthesis of imidazoles 10f-g as complex mixtures were isolated under our experimental conditions (entries 5 and 6).
The structure and regiochemistry of imidazoles 9 and 10 were confirmed by comparison of their spectral data with those reported in the literature. In the proposed mechanism, the free amidine I derived from the neutralization of amidinium hydrochloride 2 by a base adds to bromonitroalkene 8 in a Michael fashion to afford intermediate II. Intramolecular nucleophilic substitution of bromide in II in a 5-exo-tet fashion provides the cyclized intermediate nitroimidazoline III which then undergoes base mediated elimination of HNO 2 to give the product 2,5-disubstituted imidazole 9 or 10 (Scheme 2).
Trypanocidal activity studies
In the case of imidazoles 3-7 derived from nitroallylic acetates 1, the most active compound was imidazole ester 3e (2-fold more potent than the current drug benznidazole) followed by esters 3b and then 3a, presenting IC 50 /24 h values of 51.1, 102.0 and 111.9 µM, respectively. These three imidazoles possess a phenyl group at position 2 and an aryl group at position 5 bearing weakly or strongly electron donating substituent(s) at the ortho/para position(s). The presence of groups such as CH 2 CO 2 H, CH 2 CONH 2 , CH 2 CH 2 OH, and CH 2 CH 2 N 3 at position 5 did not improve the activity as compared to CH 2 CO 2 Et (Scheme 1 and Table 1 ). This was also a motivating factor to synthesize imidazoles of types 9 and 10 wherein there is no substituent at position 5. The evaluation of the IC 50 values of imidazoles 9 and 10 in Tables 3 and 4 reveal that imidazole 9m bearing a phenyl group at position 2 and a naphthyl group at position 4 is 3-fold more active (IC 50 /24 h = 35.5 µM, Table 3 , entry 13) than the standard benznidazole. This is followed by 9o with a phenyl group at position 2 and a cyclohexyl group at position 4 (IC 50 /24 h = 99.6 µM, Table 3 , entry 15) which is as active as benznidazole. Imidazole 10b with a p-tolyl group at position 2 and a p-anisyl group at position 4 (IC 50 / 24 h = 123.0 µM, Table 4 , entry 1) is marginally less active than benznidazole. Other analogs that show appreciable activity which is attributable to the substituents at positions 2 and 4 are 9p (Ph, n-Bu, IC 50 /24 h = 151.1 µM, In general, our compounds possess low molecular weight, partition coefficient and polar surface area values adhering to the Lipinski's rules. For the compounds described herein, the hydrophobicity appears sufficient for penetrating the biological membranes of the parasite, as determined by Lipinski's rule of 5 (clog P < 5, molecular weight ≤500, and PSA ≤ 140 Å 2 , number of hydrogen bond acceptors <10 and donors <5). 37 Finally, a chemical informatics approach 38 was used to calculate the octanol-water partition coefficient (clog P value) and molecular polar surface area (PSA) for the most active compounds 3a, 3b, 3e, 9m, 9o and 10b, with IC 50 /24 h in the range of 35.5 to 123 µM. The clog P and PSA values were in the range of 4.16-4.87 and 28.68-73.46 , respectively.
Conclusions
Substituted imidazoles have been synthesized using amidines via a cascade S N 2′-intramolecular aza-Michael addition-elimination with nitroallylic acetates and via a cascade Michael addition-intramolecular S N 2 reaction with α-bromonitroalkenes. Imidazoles belonging to both the series have been screened against T. cruzi bloodstream trypomastigotes, an infective form of the protozoa that causes Chagas disease.
Scheme 2 Possible mechanism for formation of imidazoles 9 and 10 via [3 + 2] cycloaddition of amidines 2 with bromonitroalkenes 8.
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Experimental section
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Trypanocidal assay
Stock solutions of the compounds were prepared in dimethyl sulfoxide (DMSO), with the final concentration of the latter in the experiments never exceeding 0.4%. Preliminary experiments showed that DMSO has no deleterious effect on the parasites when its concentration is up to 4%. T. cruzi bloodstream trypomastigotes (Y strain) were obtained at the peak of parasitaemia from infected albino mice, purified by differential centrifugation and resuspended in RPMI to a parasite concentration of 10 7 cells per mL in the presence of 10% of mouse blood. This suspension (100 µL) was added into the same volume of each compound previously prepared at twice the desired final concentrations for 24 h at 4°C. Cell quantification was performed in a Neubauer chamber and the trypanocidal activity was expressed as IC 50 /24 h, corresponding to the concentration that leads to the lysis of 50% of the parasites. The activity of standard benznidazole was reported earlier. 41 It is different from that reported by Moraes et al. 42 due to different experimental conditions.
General procedure for the synthesis of imidazoles from nitroallylic acetates
To a stirred solution of amidine 2 (0.24 mmol) and DABCO (61 mg, 0.5 mmol) in acetonitrile (2 mL), MBH acetate 1 (0.2 mmol) was added. After the completion of the reaction, monitored by TLC, the solvent was removed in vacuo and the crude product was purified by silica gel column chromatography by gradient elution with pet. ether/ethyl acetate (20-70%). 6, 149.1, 148.6, 144.7, 134.5, 129.0, 128.3, 126.7, 124.7, 119.8, 111.3, 110.9, 61.6, 56.0, 55.9, 32.7, 14.3 
Ethyl 2-(4-(3,4-dimethoxyphenyl)-2-p-tolyl-1H-imidazol-5-yl)-acetate (3v
2-(4-(4-Methoxyphenyl)-2-phenyl-1H-imidazol-5-yl)ethan-1-ol (4a).
To a stirred suspension of LAH (16 mg, 0.4 mmol) in THF (3 mL) at 0°C, was added slowly a solution of ester 3 (70 mg, 0.2 mmol) in THF (1 mL). The reaction mixture was allowed to warm to ambient temperature and stirred for an additional 12 h. After the completion of the reaction (monitored by TLC), a saturated solution of NH 4 Cl (5 mL) was added, the resulting mixture was filtered through a pad of celite and the filtrate was concentrated. To the aqueous layer was added ethyl acetate (10 mL), the layers were separated and the organic phase was washed with brine (3 × 5 mL) and water (3 × 5 mL) and dried over anhyd. Na 2 SO 4 . The combined organic layers were concentrated in vacuo and the residue was subjected to silica gel column chromatography (72% EtOAc/ pet. ether). 
5-(2-Azidoethyl)-4-(4-methoxyphenyl)-2-phenyl-1H-imidazole (7a).
To a stirred solution of imidazolyl alcohol 4a (147 mg, 0.5 mmol) in dry CH 2 Cl 2 (10 mL) triethylamine (0.21 mL, 152 mg, 1.5 mmol, 3 equiv.) was added at 0°C, followed by mesyl chloride (0.12 mL, 172 mg, 1.5 mmol, 3 equiv.). The resulting reaction mixture was stirred for 1 h at 0°C and then for an additional 2 h at room temperature. After the completion of the reaction, the reaction mixture was diluted with water (10 mL), extracted with CH 2 Cl 2 (3 × 10 mL) and the combined organic layers were thoroughly washed with water (3 × 10 mL) to remove the excess mesyl chloride followed by saturated NaHCO 3 (3 × 10 mL) and 5% dil. HCl (3 × 10 mL). The organic layer was dried over anhyd. Na 2 SO 4 and concentrated in vacuo. The crude mesylate was suspended in DMF (8 mL) to which NaN 3 (130 mg, 2 mmol, 4 equiv.) was added followed by TBAB (16 mg, 0.05 mmol, 10 mol%). Then the reaction mixture was heated at 90°C for 12 h. The reaction mixture was diluted with water (10 mL) and extracted with ethyl acetate (3 × 10 mL). The combined organic layers were concentrated in vacuo and the residue was purified by silica gel column chromatography to afford diazide 7a as colorless oil; yield 60%, 95 mg; IR (neat, cm 1, 145.9, 130.2, 128.9 (×2), 128.7, 125.4, 114.3, 55.5, 51.1, 26.7 General procedure for the synthesis of imidazoles 9 and 10 from α-bromonitroalkenes 8 and amidines 2
To a stirred solution of α-bromonitroalkene 8 (0.2 mmol) in CH 3 CN (3 mL), was added benzamidine hydrochloride 2 (0.2 mmol) followed by Cs 2 CO 3 (195 mg, 0.6 mmol) at room temperature. The stirring was continued at room temperature and the completion of the reaction was monitored by TLC analysis. The crude reaction mixture was directly subjected to silica gel column chromatography by eluting with 15-50% EtOAc-pet. ether (gradient elution). 9, 147.2, 138.6, 130.1, 128.9, 128.7, 126.5, 125.7, 125.3, 117.3, 114.3, 55.4 4, 138.9, 130.2, 128.8, 128.7, 125.8, 125.7, 117.7, 117.5, 111.6, 108.7, 55.9, 55.7 28 No experimental data are available. 6, 138.9, 132.4, 129.8, 129.0, 128.9, 128.8, 127.3, 125.8, 125.2, 118. The experimental data are consistent with those reported in the literature. 1, 139.7, 135.7, 131.0, 130.7, 129.3, 128.9, 128.3, 125.1, 124.6, 116.2, 20.9 6, 130.6, 128.7, 128.1, 126.3, 124.9, 15.0 9, 139.3, 138.9, 132.7, 131.5, 129.9, 129.1, 129.0, 126.4, 125.8, 117 8.08 (s, 1H), 8.02 (d, J = 6.4 Hz, 2H), 2H), 7.48 (t, J = 5.9 Hz, 2H), 3H) ; 13 C NMR (125 MHz, DMSO-d 6 ) δ 146. 4, 139.5, 137.1, 130.6, 130.4, 128.8, 128.7, 128.3, 126.8, 125.1, 123.3, 122.1, 115.4 (br s, 1H), 1H), 7.83 (d, J = 7.7 Hz, 2H), 7.72 (br d, J = 6.7 Hz, 1H), 7.58 (t, J = 7.7 Hz, 1H), 4H), 7.31 (s, 1H) ; 13 C NMR (125 MHz, DMSO-d 6 ) δ 148. 2, 146.3, 136.3, 131.6, 130.2, 129.2, 128.8, 128.5, 127.5, 127.1, 125.0, 123.3, 116.6 5, 136.4, 135.2, 129.9, 129.0, 129.0, 127.8, 125.8, 123.8, 122.8, 116.4 8, 138.2, 133.7, 130.9, 130.7, 130.3, 128.9, 128.4, 128.3, 127.5, 126.3, 126.2, 126.1, 125.8, 125.6, 125 9, 137.4, 136.1, 129.9, 129.0, 129.0, 128.8, 127.5, 127.5, 126.3, 125.9, 122.7, 117.7 7, 142.8, 129.8, 129.0, 128.8, 125.6, 118.1, 36.0, 33.1, 26.3, 26. 9, 130.3, 129.0, 128.5, 125.4, 119.7, 31.6, 26.4, 22.5, 14.0 9, 137.4, 129.3, 128.0, 125.7, 124.9, 114.0, 55.1, 20.9 145.9, 139.1, 134.8, 131.7, 130.1, 128.6, 126.6, 125.8, 124.9, 123.8, 117.7, 114.3, 55.5 9, 139.3, 126.3, 125.2, 117.4, 114.3, 55.4, 17.5 
4-(4-Methoxyphenyl)-2-phenyl-1H-imidazole (9a
4-(Benzo[d][1,3]dioxol-5-yl)-2-phenyl-1H-imidazole (9c
